Pascal Biosciences Inc (PAS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pascal Biosciences Inc (PAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014299
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve their ability to attack cancers, infections and autoimmune diseases. Its research programs comprise Major Histocompatibility Complex I, that restores the immune system’s ability to recognize and destroy cancer cells. Pascal Biosciences offers research on calcium channel blockers that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection. The company also provides CD74, a chaperone protein that aids the immune system to combat infections and cancers. Pascal Biosciences is headquartered in Vancouver, British Columbia, Canada.

Pascal Biosciences Inc (PAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biommune Enters into Agreement with University of British Columbia 10
Licensing Agreements 11
Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11
Equity Offering 12
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 12
BioMmune Raise USD0.8 Million in Private Placement of Units 13
Acquisition 14
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 14
Pascal Biosciences Inc – Key Competitors 15
Pascal Biosciences Inc – Key Employees 16
Pascal Biosciences Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
May 09, 2017: Pascal Biosciences Creates Development Science Lab in Seattle WA 18
Corporate Communications 19
Sep 20, 2016: BioMmune Appoints Thomas Gadek, PhD, to Board of Directors 19
Apr 22, 2016: BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President 20
Other Significant Developments 21
Mar 30, 2017: bioMmune Announces Name Change to Pascal Biosciences 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biommune Enters into Agreement with University of British Columbia 10
Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 12
BioMmune Raise USD0.8 Million in Private Placement of Units 13
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 14
Pascal Biosciences Inc, Key Competitors 15
Pascal Biosciences Inc, Key Employees 16

★海外企業調査レポート[Pascal Biosciences Inc (PAS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Breville Group Limited (BRG):企業の財務・戦略的SWOT分析
    Breville Group Limited (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Versum Materials, Inc.:企業の戦略的SWOT分析
    Versum Materials, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Check Point Software Technologies Ltd (CHKP):企業の財務・戦略的SWOT分析
    Check Point Software Technologies Ltd (CHKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Seoul National University Hospital:企業の戦略的SWOT分析
    Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務分析
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Grifols SA (GRF):企業の財務・戦略的SWOT分析
    Grifols SA (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Black Hills Power Inc:電力:M&Aディール及び事業提携情報
    Summary Black Hills Power Inc (Black Hills), a subsidiary of Black Hills Corp, is a power company that generates, transmits and distributes electricity. The company generates electricity through coal, gas, and oil resources. Its services include electricity and natural gas transmission and distribut …
  • StealthGas Inc (GASS):石油・ガス:M&Aディール及び事業提携情報
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. It transports byproducts of crude oil and natural gas including but …
  • The Procter & Gamble Co:戦略・SWOT・企業財務分析
    The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report Summary The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Immunodiagnostic Systems Holdings plc (IDH):医療機器:M&Aディール及び事業提携情報
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Stryker Corp (SYK):医療機器:M&Aディール及び事業提携情報
    Summary Stryker Corp (Stryker) is a medical technology company that manufactures an array of orthopaedic, medical and surgical, and neurotechnology and spine products and allied services. Its major products include orthopaedic implants; surgical equipment and surgical navigation systems; patient han …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • Schneider Electric SE (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Cesca Therapeutics Inc (KOOL)-医療機器分野:企業M&A・提携分析
    Summary Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device di …
  • Actuated Medical Inc:企業の製品パイプライン分析2018
    Summary Actuated Medical Inc (Actuated Medical) is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems and MRI compatible systems. Its controlled tissue penetration systems use …
  • Prodware SA:企業の戦略・SWOT・財務情報
    Prodware SA - Strategy, SWOT and Corporate Finance Report Summary Prodware SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Guess Inc (GES):企業の財務・戦略的SWOT分析
    Guess Inc (GES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Saudi Telecom Co (7010):企業の財務・戦略的SWOT分析
    Saudi Telecom Co (7010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Genzyme Corp:医療機器:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechno …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆